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Abstract 26 
Zearalenone (ZEN) is a mycotoxin produced by Fusarium species. ZEN mainly appears in 27 
cereals and related foodstuffs, causing reproductive disorders in animals, due to its 28 
xenoestrogenic effects. The main reduced metabolites of ZEN are α-zearalenol (α-ZEL) and 29 
β-zearalenol (β-ZEL). Similarly to ZEN, ZELs can also activate estrogen receptors, moreover, 30 
α-ZEL is the most potent endocrine disruptor among these three compounds. Serum albumin 31 
is the most abundant plasma protein in the circulation, it affects the tissue distribution and 32 
elimination of several drugs and xenobiotics. Although ZEN binds to albumin with high 33 
affinity, albumin-binding of α-ZEL and β-ZEL has not been investigated. In this study, the 34 
complex formation of ZEN, α-ZEL, and β-ZEL with human (HSA), bovine (BSA), porcine 35 
(PSA), and rat serum albumins (RSA) was investigated by fluorescence spectroscopy, affinity 36 
chromatography, thermodynamic studies, and molecular modeling. Our main observations are 37 
as follows: (1) ZEN binds with higher affinity to albumins than α-ZEL and β-ZEL. (2) The 38 
low binding affinity of β-ZEL towards albumin may result from its different binding position 39 
or binding site. (3) The binding constants of the mycotoxin-albumin complexes significantly 40 
vary with the species. (4) From the thermodynamic point of view, the formation of ZEN-HSA 41 
and ZEN-RSA complexes are similar, while the formation of ZEN-BSA and ZEN-PSA 42 
complexes are markedly different. These results suggest that the toxicological relevance of 43 
ZEN-albumin and ZEL-albumin interactions may also be species-dependent. 44 
 45 
Keywords: zearalenone; zearalenols; serum albumin; species-dependent alternations; 46 
fluorescence spectroscopy  47 
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Introduction 48 
Zearalenone (ZEN; Fig. 1) is a Fusarium-derived mycotoxin, which occurs as a contaminant 49 
in cereals (e.g., maize, wheat, or barley), spices, milk, and beer (Yazar and Omurtag 2008; 50 
Maragos 2010). Because ZEN is a xenoestrogen, it induces reproductive disorders in farm 51 
animals (EFSA, 2017; Shier et al. 2001). After its absorption from the gastrointestinal tract, 52 
ZEN is extensively biotransformed, during which reduced metabolites and glucuronic acid 53 
conjugates are formed (EFSA, 2017). Most important reduced derivatives of ZEN are α-54 
zearalenol (α-ZEL) and β-zearalenol (β-ZEL) (Fig. 1), however, lower amounts of 55 
zearalanone, α-zearalanol, and β-zearalanol are produced as well (Minervini and Dell’Aquila 56 
2008). ZELs also bind with high affinity to estrogen receptors, α-ZEL even exerts 57 
significantly stronger toxic effect than the parent compound ZEN (Fleck et al. 2017; Frizzell 58 
et al. 2011; Filannino et al. 2011). Besides ZEN, the appearance of ZELs has been also 59 
reported in some foodstuffs, including milk and soy meal (Huang et al. 2014; Schollenberger 60 
et al. 2006). ZEN and its metabolites are rapidly absorbed from the gastrointestinal tract and 61 
distributed among several organs/tissues; glucuronic acid conjugates of ZEN and ZELs are 62 
excreted through the biliary route then undergo enterohepatic circulation (EFSA, 2017).  63 
Serum albumin is the most abundant plasma protein in the circulation. Albumin maintains the 64 
oncotic pressure of blood as well as it has important buffer, antioxidant, and pseudo-65 
enzymatic functions. Albumin forms non-covalent complexes with several endogenous 66 
compounds, drugs, and xenobiotics, affecting significantly their tissue distribution and plasma 67 
elimination half-life (Fanali et al. 2012; Yamasaki et al. 2013). Albumin is built up from three 68 
domains (I, II, and III), each domain contains two subdomains (A and B). The two major 69 
binding sites of albumin are located in subdomain IIA (Sudlow’s Site I) and subdomain IIIA 70 
(Sudlow’s Site II). However, recent studies highlighted the importance of a third binding site 71 
located in subdomain IB (Heme binding site) (Fanali et al. 2012; Zsila 2013). As previous 72 
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studies demonstrated, many mycotoxins (e.g., aflatoxins, citrinin, deoxynivalenol, 73 
ochratoxins, patulin, and ZEN) form stable non-covalent complexes with albumins (Poór et al. 74 
2012, 2015, 2017a, 2017b; Li et al. 2013; Perry et al. 2003; Yuqin et al. 2014). Some of these 75 
interaction could be of high toxicological importance. Aflatoxins, deoxynivalenol, and patulin 76 
form less stable complexes with human albumin (K ~ 104 L/mol) (Poór et al. 2017a; Li et al. 77 
2013; Yuqin et al. 2014) than citrinin and ZEN (K ~ 105 L/mol) (Poór et al. 2015, 2017b), 78 
while the stability of ochratoxin A-albumin complex is extremely high (K ~ 107 L/mol) 79 
(Kőszegi and Poór 2016; Sueck et al., 2018).  80 
As demonstrated in our previous study, ZEN binds to human albumin with high affinity, 81 
occupying a non-conventional binding site between subdomains IIA and IIIA (Poór et al. 82 
2017b). In another study, Ma et al. investigated the complex formation of ZEN with bovine 83 
albumin (Ma et al. 2018). Based on these two studies, the complex formation of ZEN with 84 
human and bovine albumins shows large differences. Therefore, the investigation of species-85 
dependence of ZEN-albumin interactions seems reasonable. Furthermore, while ZEN is 86 
known to bind to albumin with high affinity, we have no information regarding the 87 
interactions of α- and β-ZEL with serum albumin. 88 
In this study, the interactions of ZEN, α-ZEL, and β-ZEL with human (HSA), bovine (BSA), 89 
porcine (PSA), and rat (RSA) serum albumins were investigated using fluorescence 90 
spectroscopy in order to determine the binding constants of mycotoxin-albumin complexes by 91 
fluorescence quenching method. The mycotoxin-HSA interactions were also evaluated by 92 
high performance affinity chromatography (HPAC). To characterize further the species-93 
dependence of the albumin-binding of ZEN, thermodynamic studies were performed. Finally, 94 
mycotoxin-albumin interactions were also examined employing molecular modeling studies. 95 
Our results demonstrate that α-ZEL and especially β-ZEL binds with significantly lower 96 
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affinity to albumin than ZEN, and albumin-binding of each mycotoxin (ZEN, α-ZEL, and β-97 
ZEL) show very significant species-dependence. 98 
 99 
Materials and methods 100 
 Reagents 101 
All reagents and solvents were spectroscopic or analytical grade. Zearalenone (ZEN; MW = 102 
318.36 g/mol), α-zearalenol (α-ZEL; MW = 320.38 g/mol), β-zearalenol (β-ZEL; MW = 103 
320.38 g/mol), human serum albumin (HSA; MW = 66.4 kDa), bovine serum albumin (BSA; 104 
MW = 66.4 kDa), porcine serum albumin (PSA; MW = 67.5 kDa), rat serum albumin (RSA; 105 
MW = 64.6 kDa), and warfarin were purchased from Sigma-Aldrich. Stock solutions of 106 
mycotoxins (5000 μmol/L; ZEN: 1.592 g/L; ZELs: 1.601 g/L) were prepared in ethanol 107 
(VWR, spectroscopic grade) and stored at –20°C. 108 
 109 
Spectroscopic measurements 110 
Fluorescence and absorption spectra were recorded employing a Hitachi F-4500 fluorimeter 111 
(Tokyo, Japan) and a Specord Plus 210 (Analytic Jena AG, Jena, Germany) UV-Vis 112 
spectrophotometer, respectively. Mycotoxin-albumin interactions were investigated in 113 
phosphate buffered saline (PBS: 8.00 g/L NaCl, 0.20 g/L KCl, 1.81 g/L Na2HPO4 x 2H2O, 114 
0.24 g/L KH2PO4; pH = 7.4). Spectroscopic measurements were carried out in the presence of 115 
air, at +25°C (except thermodynamic studies). 116 
Complex formation of ZEN and its reduced metabolites with serum albumins was examined 117 
based on fluorescence quenching effects of the mycotoxins, applying the Stern-Volmer 118 
equation: 119 
𝐼0
𝐼
=  1 + 𝐾𝑆𝑉 × [𝑄]    (1) 120 
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where I and I0 are the emission intensities of albumins with and without mycotoxins, 121 
respectively. KSV (unit: L/mol) is the Stern-Volmer quenching constant and [Q] is the molar 122 
concentration of the quencher (ZEN or ZELs). To eliminate the inner-filter effects of 123 
mycotoxins, emission intensities were corrected based on the following equation (Poór et al. 124 
2017a): 125 
𝐼𝑐𝑜𝑟 = 𝐼𝑜𝑏𝑠 × 𝑒
(𝐴𝑒𝑥+𝐴𝑒𝑚)/2  (2) 126 
where Icor and Iobs denote the corrected and observed emission intensities, respectively; while 127 
Aex and Aem are the absorbance of mycotoxins at 295 and 340 nm, respectively.  128 
Binding constants (K; unit: L/mol) of mycotoxin (MT)-serum albumin (SA) complexes were 129 
calculated by non-linear fitting using Hyperquad2006 program package (Poór et al. 2018; 130 
Sueck et al., 2018), during which the following equations were implemented in the 131 
Hyperquad code: 132 
𝑝𝑆𝐴 + 𝑞𝑀𝑇 ↔ 𝑆𝐴𝑝𝑀𝑇𝑞   (3) 133 
𝛽𝑝𝑞 =
[𝑆𝐴𝑝𝑀𝑇𝑞]
[𝑆𝐴]𝑝[𝑀𝑇]𝑞
    (4) 134 
where p and q denote the coefficients which indicate the stoichiometry associated with the 135 
equilibrium. All equilibrium constants (β) were defined as overall binding constants.  136 
𝑆𝐴 + 𝑀𝑇 ↔ 𝑆𝐴 𝑀𝑇      𝛽1 =
[𝑆𝐴 𝑀𝑇]
[𝑆𝐴][𝑀𝑇]
    (5) 137 
𝑆𝐴 + 𝑞𝑀𝑇 ↔ 𝑆𝐴 𝑀𝑇𝑞      𝛽𝑞 =
[𝑆𝐴 𝑀𝑇𝑞]
[𝑆𝐴][𝑀𝑇]𝑞
   (6) 138 
The relationship between the overall binding constants and the stepwise binding constants 139 
was calculated by Hyperquad based on the followings. 140 
𝛽1 = 𝐾1;   𝛽𝑞 = 𝐾1 × 𝐾2 … × 𝐾𝑞  (7) 141 
The stoichiometry and binding constants of mycotoxin-albumin complexes were determined 142 
by the model associated with the lowest standard deviation.  143 
 144 
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High performance affinity chromatography (HPAC) 145 
Mycotoxin-HSA complex formation was confirmed by HPAC analyses at room temperature. 146 
The HPLC system (Jasco) was equipped with an intelligent pump (PU-980), a degasser (DG-147 
2080-54), a manual injector with a 5 µl-sample loop and a diode-array detector (MD 2010 148 
Plus). Data were recorded and evaluated by ChromNAV Software. The eluent which 149 
contained isopropanol (HPLC grade, VWR) and 0.01 mol/L pH 7.0 ammonium acetate buffer 150 
(15:85 v/v%) was pumped with 0.5 mL/min flow rate through an injector (Rheodyne 7725i) 151 
and the HPAC column coated with immobilized HSA (50 x 3.0 mm, 5 µm particle size, 152 
Chiralpak® HSA). The isocratically eluted compounds were detected by diode-array detector 153 
at 235 nm. 154 
 155 
Thermodynamic studies 156 
In the thermodynamic studies, fluorescence spectra were recorded using Fluorolog τ3 157 
spectrofluorometric system (Jobin-Yvon/SPEX) at six different temperatures (298, 301, 304, 158 
307, 310, and 313 K). Based on our earlier work (Poór et al. 2017b), binding constants of 159 
ZEN-albumin complexes were calculated applying Hyperquad2006 program package (Gans et 160 
al. 1996) assuming 1:1 stoichiometry. Thermodynamic parameters associated to the complex 161 
formations between ZEN and albumins were computed using the van’t Hoff equation:  162 
𝑙𝑜𝑔𝐾 = −
∆𝐺
𝑅𝑇
= −
∆𝐻
2.303∙𝑅∙𝑇
+
∆𝑆
2.303∙𝑅
  (8) 163 
where ΔG, ΔH, and ΔS reflect the Gibbs free energy, enthalpy, and entropy changes of the 164 
binding reaction, respectively; while R is the gas constant and T refers the temperature. 165 
 166 
Modeling studies 167 
The ligand molecules (α-ZEL and β-ZEL) were built in Maestro (Schrödinger 2013). The raw 168 
structure was energy minimized, using the semi-empirical quantum chemistry program 169 
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package, MOPAC (Stewart 1990) and the PM6 parameterization. The gradient norm was set 170 
to 0.001. The energy minimized structure was subjected to force calculations. The force 171 
constant matrices were positive definite. Apo crystallographic structure (PDB code: 1ao6) 172 
was used as a target molecule in our calculations. Acetyl and amide capping groups were 173 
attached to the N- and C-termini, respectively, using the Schrödinger Maestro program 174 
package v. 9.6 (Schrödinger 2013). As 1ao6 contains a homodimer structure, only chain A 175 
was used for calculations. Co-crystallized ions and water molecules were removed before 176 
minimizing the protein structure. The target molecule was minimized using a two-step 177 
protocol with the GROMACS software package (Abraham et al. 2015), including a steepest 178 
descent and a conjugate gradient step, using AMBER99-ildn force field (Lindorff-Larsen et 179 
al. 2010). Exit tolerance levels were set to 1000 and 10 kJ mol−1 nm
−1 while maximum step 180 
sizes were set to 0.5 and 0.05 nm, respectively. 181 
Using the optimized ligand and target structures, blind docking calculations were performed 182 
with AutoDock 4.2 program package (Morris et al. 2009) as described in our previous 183 
publications (Hetényi and van der Spoel 2002, 2006, 2011). Gasteiger-Marsilli partial charges 184 
were added to both ligands and target atoms using AutoDock Tools (Morris et al. 2009) and a 185 
united atom representation was applied for non-polar moieties. A grid box of 250 grid points 186 
was assigned in all axes, and 0.375 Å spacing was calculated and centered on the center of 187 
mass of the target by AutoGrid 4.2. Lamarckian genetic algorithm was used for global search. 188 
Flexibility at three active torsions was allowed on both ligands. Number of docking runs was 189 
set to 100, numbers of energy evaluations and generations were 20 million (Hetényi and van 190 
der Spoel 2002). The docked ligand copies were ordered according to AutoDock 4 scores 191 
(Morris et al. 2009), and subsequently clustered using a 2 Å distance tolerance between 192 
cluster representatives. 193 
 194 
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Results and discussion 195 
Investigation of mycotoxin-albumin interactions using fluorescence quenching method 196 
In this study, fluorescence emission spectra of albumins (2 μmol/L; HSA/BSA: 0.133 g/L; 197 
PSA/RSA: 0.135 g/L) were recorded in the presence of increasing mycotoxin concentrations 198 
(0-10 μmol/L; ZEN: 0.000-3.184 mg/L; ZELs: 0.000-3.204 mg/L) in PBS buffer (pH = 7.4; 199 
λex = 295 nm). In order to exclude the inner-filter effect, emission intensities were corrected 200 
by Eq. 2. In a concentration-dependent fashion, each tested mycotoxin induced the decrease 201 
of fluorescence at 340 nm (emission maximum of albumins), resulted from the quenching 202 
effects of ZEN and ZELs on albumins and suggesting the formation of mycotoxin-albumin 203 
complexes (Poór et al. 2015, 2017a, 2017b). The Stern-Volmer plots of mycotoxin-albumin 204 
complexes showed good linearity (Fig. 2; R2 = 0.97-0.99). Based on the mycotoxin-induced 205 
quenching of fluorescence, Stern-Volmer quenching constants (KSV) and binding constants 206 
(K) of mycotoxin-albumin complexes were calculated (see details in Spectroscopic 207 
measurements section). Both Stern-Volmer equation (Eq. 1) and Hyperquad2006 program 208 
(Eqs. 3-7) suggest 1:1 stoichiometry of complex formation. As demonstrated in Table 1, 209 
logKSV and logK values correlate, and suggest the formation of stable mycotoxin-albumin 210 
complexes (logK = 4.05-5.43). Judged from the logKSV and logK values, HSA, BSA, and PSA 211 
form the most stable complexes with ZEN followed by α-ZEL and β-ZEL, while each 212 
mycotoxin bind to RSA with similar affinity. The binding constant of ZEN-HSA complex is 213 
2.3-fold and 5.8-fold higher compared to α-ZEL-HSA and β-ZEL-HSA, respectively. ZEN 214 
and ZELs formed by far the most stable complexes with RSA, while the least stable 215 
mycotoxin-albumin complexes were typically formed with PSA. Significant species 216 
differences were observed in binding to albumin with each mycotoxin tested, approaching 10-217 
fold or higher differences when comparing the stabilities of ZEN-PSA vs. ZEN-RSA, α-ZEL-218 
BSA vs. α-ZEL-RSA, or β-ZEL-HSA vs. β-ZEL-RSA, for example. These results suggest that 219 
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the influence of albumin on the toxicokinetics of ZEN and ZELs may also be species-220 
dependent.       221 
 222 
High performance affinity chromatography of ZEN and ZELs 223 
HPAC column coated with immobilized HSA was applied to confirm the results of our 224 
fluorescence spectroscopic studies. Because the data in Table 1 indicate that ZEN and ZELs 225 
bind with significantly different affinities to HSA, it is reasonable to expect that these 226 
compounds are eluted from the HSA-HPAC column at different retention times. Applying the 227 
suggested experimental conditions of the column, we tried to elute the mycotoxins both with 228 
0.01 mol/L ammonium acetate (pH 7.0) and with 0.01 mol/L sodium phosphate (pH 7.0) 229 
buffers containing isopropanol (5-15 v/v%). In the sodium phosphate buffer, elution of ZEN 230 
was excessively delayed, therefore, further experiments were performed with the ammonium 231 
acetate buffer containing 15 v/v% isopropanol. The significant differences in the retention 232 
times of ZEN, α-ZEL, and β-ZEL (Fig. 3) clearly indicate the different binding affinities of 233 
these mycotoxins towards HSA. At pH 7.0, the longest retention time was observed for ZEN 234 
(15.6 min), while α-ZEL (8.1 min) and β-ZEL (4.6 min) were eluted more rapidly from the 235 
HSA-coated column. These results are in agreement with the spectroscopic studies, which 236 
yielded the following complex stabilities: ZEN-HSA > α-ZEL-HSA > β-ZEL-HSA (Table 1). 237 
 238 
Thermodynamic studies    239 
Serum albumins are multifunctional proteins which are highly conserved in both sequence 240 
and structure (Chruszcz et al. 2013). Therefore, it is expected that their biological behaviors, 241 
such as their ligand binding properties, are usually very similar. Indeed, the mycotoxin 242 
aflatoxin B1 and citrinin bind to different albumins with similar affinity (Poór et al. 2015, 243 
2017a). Nevertheless, some ligands, such as ochratoxin A, show marked species-dependence 244 
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(Poór et al. 2014; Kőszegi and Poór 2016). Therefore, the interactions of ZEN with different 245 
serum albumins have been analyzed in details. Since the binding constants of ZEN to albumin 246 
from various species differ substantially (Table 1), the temperature-dependence of the ZEN-247 
albumin complex formation, using HSA, BSA, PSA, and RSA was also examined. Fig. 4 248 
demonstrates the van’t Hoff plot of ZEN-albumin complexes, based on equilibrium constants 249 
determined at different temperatures. Thermodynamic parameters were calculated from the 250 
slope and the intercept after linear fitting (according to Eq. 8). The negative ΔG values 251 
suggest spontaneous interaction of ZEN with albumins at room-temperature (Table 2). These 252 
values are in the typical range of non-covalent interactions. During the formation of protein-253 
ligand complexes, the interaction forces are derived from van der Waals interactions, 254 
hydrophobic forces, multiple hydrogen bonds, and/or electrostatic interactions. 255 
Thermodynamic data give deeper insights into the nature of these binding forces (Ross and 256 
Subramanian 1981). Comparing enthalpy and entropy values raised during the formation of 257 
ZEN-albumin complexes, the higher enthalpy change is associated with smaller entropy gain 258 
resulting in an enthalpy driven process regarding ZEN-HSA and ZEN-RSA complexes in 259 
agreement with the known enthalpy-entropy compensation. Negative values of both enthalpy 260 
and entropy changes indicate that van der Waals forces and hydrogen bond formation are 261 
involved in the complex formation of ZEN with HSA and RSA. Furthermore, the low entropy 262 
gain of these interactions reflects that ZEN may keep its solvation shell during the complex 263 
formation processes.  264 
The formation of ZEN-BSA and ZEN-PSA complexes is entropy driven, in which smaller 265 
enthalpy changes are associated with higher entropy gain, showing enthalpy-entropy 266 
compensation. The positive values of entropy changes suggest the partial decomposition of 267 
the solvation shell of the interacting molecules and/or local changes (e.g., unfolding) in the 268 
conformation of albumin. The negative enthalpy change is associated with positive entropy 269 
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change, suggesting the role of electrostatic forces in the formation of ZEN-BSA and ZEN-270 
PSA complexes. According to these thermodynamic data, the binding characteristics of the 271 
more stable ZEN-RSA and ZEN-HSA complexes seem different from those of the less stable 272 
ZEN-BSA and ZEN-PSA. 273 
HSA and BSA are extensively studied macromolecules. Due to their structural similarity, the 274 
significantly cheaper BSA is more commonly applied to examine albumin-ligand interactions 275 
than HSA (Poór et al. 2014). However, some previous studies demonstrated that major 276 
differences may occur between HSA and BSA complexes; e.g. ochratoxin A binds to HSA 277 
with approximately 10 times higher affinity than to BSA (Poór et al. 2014). The present study 278 
gives a new example, when ligand binding shows significant species differences, as related by 279 
both the dissimilar binding constants and binding characteristics of ZEN-HSA and ZEN-BSA 280 
complexes.  281 
To further analyze the differences between HSA and BSA, the effect of ionic strength on the 282 
ZEN-HSA and ZEN-BSA interactions were also investigated in different sodium phosphate 283 
buffers (0.05-0.53 mol/L), as it is well-known that variations in ionic strength affect the 284 
albumin-ligand interactions (Kaspchak et al. 2018). High ionic strength may decrease or 285 
increase the binding constant, depending on the involvement of electrostatic or hydrophobic 286 
forces, respectively. Fig. 5 demonstrates binding constants of ZEN-HSA and ZEN-BSA 287 
complexes as a function of the ionic strength. Although the ionic strength of the media 288 
slightly affects the binding constant of the ZEN-HSA and ZEN-BSA complexes, the different 289 
binding characteristics of the two albumin species with ZEN is apparent. At an increased ionic 290 
strength higher binding affinity was observed, reflecting dominance of hydrophobic 291 
interaction between ZEN and HSA. This means that the positive entropy change associated 292 
with hydrophobic processes is also balanced by the negative contribution of entropy change 293 
caused by formation of hydrogen bonds and action of van der Waals forces (Ross and 294 
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Subramanian 1981). Therefore, hydrophobic interactions play an important role in the 295 
complex formation of ZEN with HSA. However, the investigation of ZEN-BSA interaction 296 
did not reveal a clear correlation between the ionic strength and the binding constant (Fig. 5). 297 
In the study of Ma et al. (Ma et al. 2018) on ZEN-BSA interaction, similar observations were 298 
made. Based on positive the entropy change, they proposed that hydrophobic forces played a 299 
major role, although it is held that positive entropy change with a negative enthalpy change is 300 
suggestive for the involvement of electrostatic interactions (Ross and Subramanian 1981). 301 
Considering that the partial decomposition of solvation shells of the interacting molecules 302 
facilitates hydrophobic interactions, our observation that the binding constant of ZEN-BSA 303 
complex is independent of the ionic strength suggests the involvement of hydrophobic and 304 
electrostatic interactions. 305 
 306 
Molecular modeling studies 307 
First, the similarities between HSA and three other albumins from other species (BSA, PSA, 308 
and RSA) were analyzed. Initially, Uniprot alignment of bovine (BSA), porcine (PSA), and 309 
rat (RSA) serum albumins were performed compared to HSA. The results of alignment (Fig. 310 
S1) and overall statistics (Table 3) demonstrate high similarities between serum albumins 311 
from the four species. The binding site of ZEN on HSA was described in our previous 312 
publication (Poór et al. 2017b). In the present study, the amino acid composition in the 313 
corresponding binding region was compared for HSA, BSA, PSA, and RSA (Fig. S1). The 314 
ZEN binding site in HSA, BSA, and PSA contains identical amino acids (Fig. S1), while RSA 315 
contains different amino acids at positions 205 and 478: charged K (lysine) is replaced by a 316 
bulkier, but also positively charged R (arginine), while T (threonine) is replaced by S (serine), 317 
maintaining the hydroxyl group within the binding site. These minor structural differences in 318 
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RSA might be responsible for the observation that ZEN and ZELs bind much higher affinity 319 
to RSA compared to other albumins tested.    320 
Thereafter, the available X-ray structures of BSA (4f5s) and HSA (1ao6) were compared. 321 
After their CA alignment of these two structures (Fig. S2, left), a 1.2 Å RMSD was obtained, 322 
which also demonstrates high similarity of the structures. Identical amino acids and similar 323 
amino acid conformations were observed in the binding site of ZEN in HSA and BSA (Fig. 324 
S2, right). 325 
Using the docking parameters described in our previous publication (Poór et al. 2017b), blind 326 
docking of α-ZEL and β-ZEL was performed on HSA. Then these results were compared with 327 
previous docking studies performed with ZEN (Fig. 6A). As Fig. 6 demonstrates, the binding 328 
site and binding position of α-ZEL (obtained in the first rank) on HSA were very similar those 329 
of ZEN. However, this binding site was obtained only in the seventh rank for β-ZEL (Fig. 330 
6C). The binding site of β-ZEL with the highest binding energy (ranking the first after blind 331 
docking) was found at approximately 15 Å away from the binding site of ZEN (Fig. 7). The 332 
similar binding site and position of α-ZEL on HSA explain why the affinity of α-ZEL toward 333 
HSA is relatively close to ZEN. However, the much weaker interaction of β-ZEL with HSA 334 
(compared to ZEN and α-ZEL) may result from a different binding position of β-ZEL in the 335 
same binding site (Fig. 6C) or from a different binding site of β-ZEL, which is also located 336 
between subdomains IIA and IIIA (Fig. 7). Nevertheless, modeling studies demonstrated that, 337 
similarly to ZEN, α- and β-ZEL also occupy non-conventional binding site(s) on HSA. 338 
 339 
Effects of ZEN and its reduced metabolites on warfarin-HSA interaction 340 
Our previous study demonstrated that ZEN interacts allosterically with Sudlow’s Site I 341 
ligands, thus increasing the binding affinity of warfarin towards HSA (Poór et al. 2017b). 342 
Since the albumin-bound warfarin expresses much stronger fluorescence than free warfarin, 343 
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the increase in the HSA-bound warfarin significantly enhance its fluorescence at 379 nm 344 
(Poór et al. 2015, 2017a, 2017b). To test whether or not ZELs exert similar effects, ZELs at 345 
increasing concentrations (0-10 μmol/L) were added to warfarin (1 μmol/L; 0.308 mg/L) and 346 
HSA (3.5 μmol/L; 0.233 g/L) in PBS. As Fig. 8 demonstrates, α-ZEL induced a smaller rise 347 
in the fluorescence signal of warfarin-HSA complex than ZEN. In contrast, β-ZEL caused 348 
concentration-dependent decrease in the fluorescence intensity of warfarin. Under the applied 349 
conditions, free or HSA-bound ZEN and ZELs gave negligible fluorescence as compared to 350 
warfarin-HSA complex, and the very slight inner-filter effect of mycotoxins was corrected 351 
based on Eq. 2. Therefore, the observed changes in fluorescence likely resulted from the 352 
changes in the bound fraction of warfarin in the presence of these mycotoxins. The different 353 
effect of β-ZEL further support the hypothesis that binding site or position of β-ZEL is 354 
different than that of ZEN and α-ZEL.        355 
In conclusion, fluorescence spectroscopic and HPAC studies on the interactions of ZEN, α-356 
ZEL, and β-ZEL with HSA indicated that mycotoxin-albumin complexes were formed and 357 
their stabilities decreased in the order: ZEN-HSA > α-ZEL-HSA > β-ZEL-HSA. The lower 358 
binding affinity of β-ZEL (compared to ZEN and α-ZEL) may have resulted from its different 359 
binding position or binding site on HSA. Furthermore, when comparing albumins from 360 
various species (i.e., HSA, BSA, PSA, and RSA), significant differences of ZEN-albumin and 361 
ZEL-albumin interactions were observed, even exceeding 10-fold differences in the binding 362 
constants. ZEN and ZELs typically formed the most stable complexes with RSA and the less 363 
stable complexes with PSA. Thermodynamic studies also revealed significant species 364 
differences in ZEN-albumin interactions: the binding characteristics of ZEN to HSA and RSA 365 
were similar, whereas the binding forces involved in ZEN-BSA and ZEN-PSA complex 366 
formation appear different. Thus, the in vivo toxicological relevance of ZEN-albumin and 367 
ZEL-albumin interactions may also be different in various species.  368 
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Tables 580 
Table 1 Decimal logarithmic values of the Stern-Volmer quenching constants (KSV; unit: 581 
L/mol) and binding constants (K; unit: L/mol) of mycotoxin-albumin complexes 582 
 583 
*(ZEN: zearalenone, α-ZEL: α-zearalenol, β-ZEL: β-zearalenol, HSA: human serum albumin, 584 
BSA: bovine serum albumin, PSA: porcine serum albumin, RSA: rat serum albumin)  585 
Mycotoxin-albumin 
complex* 
logKSV ± SD 
(unit of KSV: L/mol) 
logK ± SD 
(unit of K: L/mol) 
ZEN-HSA 5.09 ± 0.01 5.09 ± 0.01 
ZEN-BSA 4.81 ± 0.01 4.78 ± 0.01 
ZEN-PSA 4.56 ± 0.02 4.57 ± 0.01 
ZEN-RSA 5.50 ± 0.01 5.42 ± 0.00 
α-ZEL-HSA 4.70 ± 0.02 4.72 ± 0.00 
α-ZEL-BSA 4.54 ± 0.02 4.46 ± 0.02 
α-ZEL-PSA 4.47 ± 0.07 4.49 ± 0.01 
α-ZEL-RSA 5.32 ± 0.04 5.43 ± 0.00 
β-ZEL-HSA 4.28 ± 0.04 4.33 ± 0.00 
β-ZEL-BSA 4.27 ± 0.04 4.37 ± 0.01 
β-ZEL-PSA 4.18 ± 0.07 4.05 ± 0.05 
β-ZEL-RSA 5.29 ± 0.02 5.43 ± 0.00 
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Table 2 Thermodynamic parameters of zearalenone-albumin complexes (ZEN: zearalenone, 586 
HSA: human serum albumin, BSA: bovine serum albumin, PSA: porcine serum albumin, RSA: 587 
rat serum albumin). The parameters for the ZEN-HSA complex are from our earlier study (Poór 588 
et al., 2017) 589 
Thermodynamic 
parameters 
HSA BSA PSA RSA 
ΔH (kJ mol-1) –30.09 –3.13 –10.04 –34.20 
ΔS (J K-1 mol-1) –3.45 80.90 53.62 –10.65 
ΔG298K (kJ mol-1) –29.06 –27.25 –26.03 –31.03 
 590 
 591 
Table 3 The results of Uniprot alignment of BSA, PSA, and RSA with HSA (HSA: human 592 
serum albumin, BSA: bovine serum albumin, PSA: porcine serum albumin, RSA: rat serum 593 
albumin) 594 
Comparison to HSA Identical Residues Identity % Residues 
HSA-BSA 465 76.34 106 
HSA-PSA 462 75.86 99 
HSA-RSA 446 73.23 128 
  595 
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